Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1312 entries
Sorted by: Best Match Show Resources per page
Changes in Standard Treatments and Postoperative Outcomes for Advanced Gastric Cancer at One Institute over an 11-Year Period.

Yonago acta medica

Kader A, Miyatani K, Takaya S, Matsunaga T, Fukumoto Y, Osaki T, Saito H, Otani S, Wakatsuki T, Ikeguchi M.
PMID: 26306057
Yonago Acta Med. 2015 Jun;58(2):77-80. Epub 2015 Aug 18.

BACKGROUND: Reportedly, the recently established postoperative adjuvant chemotherapies (ADJs) with tegafur and uracil (UFT) or fluoropyrimidine S (S-1) show better survival than surgery alone in patients with advanced gastric cancer (GC). We analyzed chronological changes in postoperative prognosis of...

Cite
Kader A, Miyatani K, Takaya S, et al. Changes in Standard Treatments and Postoperative Outcomes for Advanced Gastric Cancer at One Institute over an 11-Year Period. Yonago Acta Med. 2015;58(2):77-80
Kader, A., Miyatani, K., Takaya, S., Matsunaga, T., Fukumoto, Y., Osaki, T., Saito, H., Otani, S., Wakatsuki, T., & Ikeguchi, M. (2015). Changes in Standard Treatments and Postoperative Outcomes for Advanced Gastric Cancer at One Institute over an 11-Year Period. Yonago acta medica, 58(2), 77-80.
Kader, Abdul, et al. "Changes in Standard Treatments and Postoperative Outcomes for Advanced Gastric Cancer at One Institute over an 11-Year Period." Yonago acta medica vol. 58,2 (2015): 77-80.
Kader A, Miyatani K, Takaya S, Matsunaga T, Fukumoto Y, Osaki T, Saito H, Otani S, Wakatsuki T, Ikeguchi M. Changes in Standard Treatments and Postoperative Outcomes for Advanced Gastric Cancer at One Institute over an 11-Year Period. Yonago Acta Med. 2015 Jun;58(2):77-80. Epub 2015 Aug 18. PMID: 26306057; PMCID: PMC4546959.
Copy Download .nbib Format: NLM
Efficacy and safety of laparoscopic surgery in elderly patients with colorectal cancer.

Molecular and clinical oncology

Inoue Y, Kawamoto A, Okugawa Y, Hiro J, Saigusa S, Toiyama Y, Araki T, Tanaka K, Mohri Y, Kusunoki M.
PMID: 26171203
Mol Clin Oncol. 2015 Jul;3(4):897-901. doi: 10.3892/mco.2015.530. Epub 2015 Mar 30.

Colorectal cancer (CRC) is predominantly a disease of the elderly. Elderly patients may also exhibit poorer outcomes due to the increased burden of comorbidities, functional dependency and limited life expectancy. The aim of this study was to evaluate the...

Cite
Inoue Y, Kawamoto A, Okugawa Y, et al. Efficacy and safety of laparoscopic surgery in elderly patients with colorectal cancer. Mol Clin Oncol. 2015;3(4):897-901doi: 10.3892/mco.2015.530.
Inoue, Y., Kawamoto, A., Okugawa, Y., Hiro, J., Saigusa, S., Toiyama, Y., Araki, T., Tanaka, K., Mohri, Y., & Kusunoki, M. (2015). Efficacy and safety of laparoscopic surgery in elderly patients with colorectal cancer. Molecular and clinical oncology, 3(4), 897-901. https://doi.org/10.3892/mco.2015.530
Inoue, Yasuhiro, et al. "Efficacy and safety of laparoscopic surgery in elderly patients with colorectal cancer." Molecular and clinical oncology vol. 3,4 (2015): 897-901. doi: https://doi.org/10.3892/mco.2015.530
Inoue Y, Kawamoto A, Okugawa Y, Hiro J, Saigusa S, Toiyama Y, Araki T, Tanaka K, Mohri Y, Kusunoki M. Efficacy and safety of laparoscopic surgery in elderly patients with colorectal cancer. Mol Clin Oncol. 2015 Jul;3(4):897-901. doi: 10.3892/mco.2015.530. Epub 2015 Mar 30. PMID: 26171203; PMCID: PMC4486975.
Copy Download .nbib Format: NLM
Covellite CuS nanocrystals: realizing rapid microwave-assisted synthesis in air and unravelling the disappearance of their plasmon resonance after coupling with carbon nanotubes.

Nanoscale

Kim MR, Hafez HA, Chai X, Besteiro LV, Tan L, Ozaki T, Govorov AO, Izquierdo R, Ma D.
PMID: 27304092
Nanoscale. 2016 Jul 14;8(26):12946-57. doi: 10.1039/c6nr03426h. Epub 2016 Jun 15.

Semiconductor nanocrystals that show plasmonic resonance represent an emerging class of highly promising plasmonic materials with potential applications in diverse fields, such as sensing and optical and optoelectronic devices. We report a new approach to synthesizing homogeneous covellite CuS...

Cite
Kim MR, Hafez HA, Chai X, et al. Covellite CuS nanocrystals: realizing rapid microwave-assisted synthesis in air and unravelling the disappearance of their plasmon resonance after coupling with carbon nanotubes. Nanoscale. 2016;8(26):12946-57doi: 10.1039/c6nr03426h.
Kim, M. R., Hafez, H. A., Chai, X., Besteiro, L. V., Tan, L., Ozaki, T., Govorov, A. O., Izquierdo, R., & Ma, D. (2016). Covellite CuS nanocrystals: realizing rapid microwave-assisted synthesis in air and unravelling the disappearance of their plasmon resonance after coupling with carbon nanotubes. Nanoscale, 8(26), 12946-57. https://doi.org/10.1039/c6nr03426h
Kim, Mee Rahn, et al. "Covellite CuS nanocrystals: realizing rapid microwave-assisted synthesis in air and unravelling the disappearance of their plasmon resonance after coupling with carbon nanotubes." Nanoscale vol. 8,26 (2016): 12946-57. doi: https://doi.org/10.1039/c6nr03426h
Kim MR, Hafez HA, Chai X, Besteiro LV, Tan L, Ozaki T, Govorov AO, Izquierdo R, Ma D. Covellite CuS nanocrystals: realizing rapid microwave-assisted synthesis in air and unravelling the disappearance of their plasmon resonance after coupling with carbon nanotubes. Nanoscale. 2016 Jul 14;8(26):12946-57. doi: 10.1039/c6nr03426h. Epub 2016 Jun 15. PMID: 27304092.
Copy Download .nbib Format: NLM
Simulation-based training for determination of brain death by pediatric healthcare providers.

SpringerPlus

Araki T, Yokota H, Ichikawa K, Osamura T, Satomi A, Tsuru T, Umehara M, Niitsu T, Yamamoto T, Nishiyama K.
PMID: 26266083
Springerplus. 2015 Aug 12;4:412. doi: 10.1186/s40064-015-1211-4. eCollection 2015.

BACKGROUND: Low competency for determination of brain death (BD) and unfamiliarity with Japanese BD (JBD) criteria among pediatricians were highlighted in previous nationwide studies. Because the JBD criteria were amended in 2010 to allow organ donation from pediatric brain-dead...

Cite
Araki T, Yokota H, Ichikawa K, et al. Simulation-based training for determination of brain death by pediatric healthcare providers. Springerplus. 2015;4:412doi: 10.1186/s40064-015-1211-4.
Araki, T., Yokota, H., Ichikawa, K., Osamura, T., Satomi, A., Tsuru, T., Umehara, M., Niitsu, T., Yamamoto, T., & Nishiyama, K. (2015). Simulation-based training for determination of brain death by pediatric healthcare providers. SpringerPlus, 4412. https://doi.org/10.1186/s40064-015-1211-4
Araki, Takashi, et al. "Simulation-based training for determination of brain death by pediatric healthcare providers." SpringerPlus vol. 4 (2015): 412. doi: https://doi.org/10.1186/s40064-015-1211-4
Araki T, Yokota H, Ichikawa K, Osamura T, Satomi A, Tsuru T, Umehara M, Niitsu T, Yamamoto T, Nishiyama K. Simulation-based training for determination of brain death by pediatric healthcare providers. Springerplus. 2015 Aug 12;4:412. doi: 10.1186/s40064-015-1211-4. eCollection 2015. PMID: 26266083; PMCID: PMC4531119.
Copy Download .nbib Format: NLM
Application of Pre-Column Labeling Liquid Chromatography for Canine Plasma-Free Amino Acid Analysis.

Metabolites

Azuma K, Hirao Y, Hayakawa Y, Murahata Y, Osaki T, Tsuka T, Imagawa T, Okamoto Y, Ito N.
PMID: 26771650
Metabolites. 2016 Jan 12;6(1). doi: 10.3390/metabo6010003.

Plasma-free amino acid (PFAA) levels are a useful metric for diagnosing cancer and providing a prognosis. However, the use of analysis of PFAA levels has been limited in the veterinary medicine field. We addressed the application of liquid chromatography...

Cite
Azuma K, Hirao Y, Hayakawa Y, et al. Application of Pre-Column Labeling Liquid Chromatography for Canine Plasma-Free Amino Acid Analysis. Metabolites. 2016;6(1)doi: 10.3390/metabo6010003.
Azuma, K., Hirao, Y., Hayakawa, Y., Murahata, Y., Osaki, T., Tsuka, T., Imagawa, T., Okamoto, Y., & Ito, N. (2016). Application of Pre-Column Labeling Liquid Chromatography for Canine Plasma-Free Amino Acid Analysis. Metabolites, 6(1), . https://doi.org/10.3390/metabo6010003
Azuma, Kazuo, et al. "Application of Pre-Column Labeling Liquid Chromatography for Canine Plasma-Free Amino Acid Analysis." Metabolites vol. 6,1 (2016). doi: https://doi.org/10.3390/metabo6010003
Azuma K, Hirao Y, Hayakawa Y, Murahata Y, Osaki T, Tsuka T, Imagawa T, Okamoto Y, Ito N. Application of Pre-Column Labeling Liquid Chromatography for Canine Plasma-Free Amino Acid Analysis. Metabolites. 2016 Jan 12;6(1). doi: 10.3390/metabo6010003. PMID: 26771650; PMCID: PMC4812332.
Copy Download .nbib Format: NLM
Corrigendum to "Bleomycin enhances the efficacy of sonodynamic therapy using aluminum phthalocyanine disulfonate" [Ultrason. Sonochem. 28 (2016) 161-168].

Ultrasonics sonochemistry

Osaki T, Yokoe I, Uto Y, Ishizuka M, Tanaka T, Yamanaka N, Kurahashi T, Azuma K, Murahata Y, Tsuka T, Ito N, Imagawa T, Okamoto Y.
PMID: 27291696
Ultrason Sonochem. 2017 Sep;38:751. doi: 10.1016/j.ultsonch.2016.06.002. Epub 2016 Jun 09.

No abstract available.

Cite
Osaki T, Yokoe I, Uto Y, et al. Corrigendum to "Bleomycin enhances the efficacy of sonodynamic therapy using aluminum phthalocyanine disulfonate" [Ultrason. Sonochem. 28 (2016) 161-168]. Ultrason Sonochem. 2016;38:751doi: 10.1016/j.ultsonch.2016.06.002.
Osaki, T., Yokoe, I., Uto, Y., Ishizuka, M., Tanaka, T., Yamanaka, N., Kurahashi, T., Azuma, K., Murahata, Y., Tsuka, T., Ito, N., Imagawa, T., & Okamoto, Y. (2017). Corrigendum to "Bleomycin enhances the efficacy of sonodynamic therapy using aluminum phthalocyanine disulfonate" [Ultrason. Sonochem. 28 (2016) 161-168]. Ultrasonics sonochemistry, 38751. https://doi.org/10.1016/j.ultsonch.2016.06.002
Osaki, Tomohiro, et al. "Corrigendum to "Bleomycin enhances the efficacy of sonodynamic therapy using aluminum phthalocyanine disulfonate" [Ultrason. Sonochem. 28 (2016) 161-168]." Ultrasonics sonochemistry vol. 38 (2017): 751. doi: https://doi.org/10.1016/j.ultsonch.2016.06.002
Osaki T, Yokoe I, Uto Y, Ishizuka M, Tanaka T, Yamanaka N, Kurahashi T, Azuma K, Murahata Y, Tsuka T, Ito N, Imagawa T, Okamoto Y. Corrigendum to "Bleomycin enhances the efficacy of sonodynamic therapy using aluminum phthalocyanine disulfonate" [Ultrason. Sonochem. 28 (2016) 161-168]. Ultrason Sonochem. 2017 Sep;38:751. doi: 10.1016/j.ultsonch.2016.06.002. Epub 2016 Jun 09. PMID: 27291696.
Copy Download .nbib Format: NLM
Therapeutic efficacy of bone marrow-derived mononuclear cells in diabetic polyneuropathy is impaired with aging or diabetes.

Journal of diabetes investigation

Kondo M, Kamiya H, Himeno T, Naruse K, Nakashima E, Watarai A, Shibata T, Tosaki T, Kato J, Okawa T, Hamada Y, Isobe K, Oiso Y, Nakamura J.
PMID: 25802721
J Diabetes Investig. 2015 Mar;6(2):140-9. doi: 10.1111/jdi.12272. Epub 2014 Sep 11.

AIMS/INTRODUCTION: Recent studies have shown that cell transplantation therapies, such as endothelial precursor cells, bone marrow-derived mononuclear cells (BM-MNCs) and mesenchymal stem cells, are effective on diabetic polyneuropathy through ameliorating impaired nerve blood flow in diabetic rats. Here, we...

Cite
Kondo M, Kamiya H, Himeno T, et al. Therapeutic efficacy of bone marrow-derived mononuclear cells in diabetic polyneuropathy is impaired with aging or diabetes. J Diabetes Investig. 2014;6(2):140-9doi: 10.1111/jdi.12272.
Kondo, M., Kamiya, H., Himeno, T., Naruse, K., Nakashima, E., Watarai, A., Shibata, T., Tosaki, T., Kato, J., Okawa, T., Hamada, Y., Isobe, K., Oiso, Y., & Nakamura, J. (2015). Therapeutic efficacy of bone marrow-derived mononuclear cells in diabetic polyneuropathy is impaired with aging or diabetes. Journal of diabetes investigation, 6(2), 140-9. https://doi.org/10.1111/jdi.12272
Kondo, Masaki, et al. "Therapeutic efficacy of bone marrow-derived mononuclear cells in diabetic polyneuropathy is impaired with aging or diabetes." Journal of diabetes investigation vol. 6,2 (2015): 140-9. doi: https://doi.org/10.1111/jdi.12272
Kondo M, Kamiya H, Himeno T, Naruse K, Nakashima E, Watarai A, Shibata T, Tosaki T, Kato J, Okawa T, Hamada Y, Isobe K, Oiso Y, Nakamura J. Therapeutic efficacy of bone marrow-derived mononuclear cells in diabetic polyneuropathy is impaired with aging or diabetes. J Diabetes Investig. 2015 Mar;6(2):140-9. doi: 10.1111/jdi.12272. Epub 2014 Sep 11. PMID: 25802721; PMCID: PMC4364848.
Copy Download .nbib Format: NLM
Development of Compton X-ray spectrometer for high energy resolution single-shot high-flux hard X-ray spectroscopy.

The Review of scientific instruments

Kojima S, Ikenouchi T, Arikawa Y, Sakata S, Zhang Z, Abe Y, Nakai M, Nishimura H, Shiraga H, Ozaki T, Miyamoto S, Yamaguchi M, Takemoto A, Fujioka S, Azechi H.
PMID: 27131669
Rev Sci Instrum. 2016 Apr;87(4):043502. doi: 10.1063/1.4944864.

Hard X-ray spectroscopy is an essential diagnostics used to understand physical processes that take place in high energy density plasmas produced by intense laser-plasma interactions. A bundle of hard X-ray detectors, of which the responses have different energy thresholds,...

Cite
Kojima S, Ikenouchi T, Arikawa Y, et al. Development of Compton X-ray spectrometer for high energy resolution single-shot high-flux hard X-ray spectroscopy. Rev Sci Instrum. 2016;87(4):043502doi: 10.1063/1.4944864.
Kojima, S., Ikenouchi, T., Arikawa, Y., Sakata, S., Zhang, Z., Abe, Y., Nakai, M., Nishimura, H., Shiraga, H., Ozaki, T., Miyamoto, S., Yamaguchi, M., Takemoto, A., Fujioka, S., & Azechi, H. (2016). Development of Compton X-ray spectrometer for high energy resolution single-shot high-flux hard X-ray spectroscopy. The Review of scientific instruments, 87(4), 043502. https://doi.org/10.1063/1.4944864
Kojima, Sadaoki, et al. "Development of Compton X-ray spectrometer for high energy resolution single-shot high-flux hard X-ray spectroscopy." The Review of scientific instruments vol. 87,4 (2016): 043502. doi: https://doi.org/10.1063/1.4944864
Kojima S, Ikenouchi T, Arikawa Y, Sakata S, Zhang Z, Abe Y, Nakai M, Nishimura H, Shiraga H, Ozaki T, Miyamoto S, Yamaguchi M, Takemoto A, Fujioka S, Azechi H. Development of Compton X-ray spectrometer for high energy resolution single-shot high-flux hard X-ray spectroscopy. Rev Sci Instrum. 2016 Apr;87(4):043502. doi: 10.1063/1.4944864. PMID: 27131669.
Copy Download .nbib Format: NLM
Simultaneous Spinal and Intracranial Chronic Subdural Hematoma Cured by Craniotomy and Laminectomy: A Video Case Report.

Case reports in neurology

Kanamaru H, Kanamaru K, Araki T, Hamada K.
PMID: 27194987
Case Rep Neurol. 2016 Apr 19;8(1):72-7. doi: 10.1159/000445709. eCollection 2016.

Simultaneous spinal and intracranial chronic subdural hematoma (CSDH) is a rare entity. A 67-year-old man visited our hospital due to headache after diving into a river 2 weeks before. Non-enhanced computed tomography (CT) and magnetic resonance imaging (MRI) revealed...

Cite
Kanamaru H, Kanamaru K, Araki T, et al. Simultaneous Spinal and Intracranial Chronic Subdural Hematoma Cured by Craniotomy and Laminectomy: A Video Case Report. Case Rep Neurol. 2016;8(1):72-7doi: 10.1159/000445709.
Kanamaru, H., Kanamaru, K., Araki, T., & Hamada, K. (2016). Simultaneous Spinal and Intracranial Chronic Subdural Hematoma Cured by Craniotomy and Laminectomy: A Video Case Report. Case reports in neurology, 8(1), 72-7. https://doi.org/10.1159/000445709
Kanamaru, Hideki, et al. "Simultaneous Spinal and Intracranial Chronic Subdural Hematoma Cured by Craniotomy and Laminectomy: A Video Case Report." Case reports in neurology vol. 8,1 (2016): 72-7. doi: https://doi.org/10.1159/000445709
Kanamaru H, Kanamaru K, Araki T, Hamada K. Simultaneous Spinal and Intracranial Chronic Subdural Hematoma Cured by Craniotomy and Laminectomy: A Video Case Report. Case Rep Neurol. 2016 Apr 19;8(1):72-7. doi: 10.1159/000445709. eCollection 2016. PMID: 27194987; PMCID: PMC4868945.
Copy Download .nbib Format: NLM
A Macrocyclic Fluorophore Dimer with Flexible Linkers: Bright Excimer Emission with a Long Fluorescence Lifetime.

Angewandte Chemie (International ed. in English)

Osaki H, Chou CM, Taki M, Welke K, Yokogawa D, Irle S, Sato Y, Higashiyama T, Saito S, Fukazawa A, Yamaguchi S.
PMID: 27121201
Angew Chem Int Ed Engl. 2016 Jun 13;55(25):7131-5. doi: 10.1002/anie.201602239. Epub 2016 Apr 28.

Bright fluorescent molecules with long fluorescence lifetimes are important for the development of lifetime-based fluorescence imaging techniques. Herein, a molecular design is described for simultaneously attaining long fluorescence lifetime (τ) and high brightness (ΦF ×ɛ) in a system that...

Cite
Osaki H, Chou CM, Taki M, et al. A Macrocyclic Fluorophore Dimer with Flexible Linkers: Bright Excimer Emission with a Long Fluorescence Lifetime. Angew Chem Int Ed Engl. 2016;55(25):7131-5doi: 10.1002/anie.201602239.
Osaki, H., Chou, C. M., Taki, M., Welke, K., Yokogawa, D., Irle, S., Sato, Y., Higashiyama, T., Saito, S., Fukazawa, A., & Yamaguchi, S. (2016). A Macrocyclic Fluorophore Dimer with Flexible Linkers: Bright Excimer Emission with a Long Fluorescence Lifetime. Angewandte Chemie (International ed. in English), 55(25), 7131-5. https://doi.org/10.1002/anie.201602239
Osaki, Hiroshi, et al. "A Macrocyclic Fluorophore Dimer with Flexible Linkers: Bright Excimer Emission with a Long Fluorescence Lifetime." Angewandte Chemie (International ed. in English) vol. 55,25 (2016): 7131-5. doi: https://doi.org/10.1002/anie.201602239
Osaki H, Chou CM, Taki M, Welke K, Yokogawa D, Irle S, Sato Y, Higashiyama T, Saito S, Fukazawa A, Yamaguchi S. A Macrocyclic Fluorophore Dimer with Flexible Linkers: Bright Excimer Emission with a Long Fluorescence Lifetime. Angew Chem Int Ed Engl. 2016 Jun 13;55(25):7131-5. doi: 10.1002/anie.201602239. Epub 2016 Apr 28. PMID: 27121201.
Copy Download .nbib Format: NLM
Discrimination between Malignant and Benign Vertebral Fractures Using Magnetic Resonance Imaging.

Asian spine journal

Takigawa T, Tanaka M, Sugimoto Y, Tetsunaga T, Nishida K, Ozaki T.
PMID: 28670417
Asian Spine J. 2017 Jun;11(3):478-483. doi: 10.4184/asj.2017.11.3.478. Epub 2017 Jun 15.

STUDY DESIGN: Retrospective analysis using magnetic resonance imaging (MRI).PURPOSE: To identify MRI features that could discriminate benign from malignant vertebral fractures.OVERVIEW OF LITERATURE: Discrimination between benign and malignant vertebral fractures remains challenging, particularly in patients with osteoporosis and cancer....

Cite
Takigawa T, Tanaka M, Sugimoto Y, et al. Discrimination between Malignant and Benign Vertebral Fractures Using Magnetic Resonance Imaging. Asian Spine J. 2017;11(3):478-483doi: 10.4184/asj.2017.11.3.478.
Takigawa, T., Tanaka, M., Sugimoto, Y., Tetsunaga, T., Nishida, K., & Ozaki, T. (2017). Discrimination between Malignant and Benign Vertebral Fractures Using Magnetic Resonance Imaging. Asian spine journal, 11(3), 478-483. https://doi.org/10.4184/asj.2017.11.3.478
Takigawa, Tomoyuki, et al. "Discrimination between Malignant and Benign Vertebral Fractures Using Magnetic Resonance Imaging." Asian spine journal vol. 11,3 (2017): 478-483. doi: https://doi.org/10.4184/asj.2017.11.3.478
Takigawa T, Tanaka M, Sugimoto Y, Tetsunaga T, Nishida K, Ozaki T. Discrimination between Malignant and Benign Vertebral Fractures Using Magnetic Resonance Imaging. Asian Spine J. 2017 Jun;11(3):478-483. doi: 10.4184/asj.2017.11.3.478. Epub 2017 Jun 15. PMID: 28670417; PMCID: PMC5481604.
Copy Download .nbib Format: NLM
Clinical systemic lupeol administration for canine oral malignant melanoma.

Molecular and clinical oncology

Yokoe I, Azuma K, Hata K, Mukaiyama T, Goto T, Tsuka T, Imagawa T, Itoh N, Murahata Y, Osaki T, Minami S, Okamoto Y.
PMID: 25469276
Mol Clin Oncol. 2015 Jan;3(1):89-92. doi: 10.3892/mco.2014.450. Epub 2014 Oct 30.

Canine oral malignant melanoma (COMM) is the most aggressive malignant tumor in dogs. Lupeol is a triterpene extracted from various fruits and vegetables that reportedly inhibits melanoma cell proliferation

Cite
Yokoe I, Azuma K, Hata K, et al. Clinical systemic lupeol administration for canine oral malignant melanoma. Mol Clin Oncol. 2014;3(1):89-92doi: 10.3892/mco.2014.450.
Yokoe, I., Azuma, K., Hata, K., Mukaiyama, T., Goto, T., Tsuka, T., Imagawa, T., Itoh, N., Murahata, Y., Osaki, T., Minami, S., & Okamoto, Y. (2015). Clinical systemic lupeol administration for canine oral malignant melanoma. Molecular and clinical oncology, 3(1), 89-92. https://doi.org/10.3892/mco.2014.450
Yokoe, Inoru, et al. "Clinical systemic lupeol administration for canine oral malignant melanoma." Molecular and clinical oncology vol. 3,1 (2015): 89-92. doi: https://doi.org/10.3892/mco.2014.450
Yokoe I, Azuma K, Hata K, Mukaiyama T, Goto T, Tsuka T, Imagawa T, Itoh N, Murahata Y, Osaki T, Minami S, Okamoto Y. Clinical systemic lupeol administration for canine oral malignant melanoma. Mol Clin Oncol. 2015 Jan;3(1):89-92. doi: 10.3892/mco.2014.450. Epub 2014 Oct 30. PMID: 25469276; PMCID: PMC4251128.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1312 entries